Rezera Inc. SEC filings RZRA
Rezera Inc. has 5 filings in SEC EDGAR's recent list, going back to Jul 7, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-1/A | Amended registration statement | Nov 5, 2026 | — |
| S-1 | Registration statement | Oct 21, 2026 | — |
| DRS/A | Filing | Sep 22, 2026 | — |
| DRS/A | Filing | Aug 21, 2026 | — |
| DRS | Filing | Jul 7, 2026 | — |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RZRA
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC CIK
- 2141583
- Former names
- NODTHERA INC. (until Aug 21, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.